{"altmetric_id":3852049,"counts":{"readers":{"mendeley":17,"citeulike":0,"connotea":0},"facebook":{"unique_users_count":1,"unique_users":["291286767653940"],"posts_count":1},"total":{"posts_count":38},"twitter":{"unique_users_count":36,"unique_users":["ONCOLOGYeditor","RielyMD","VivekSubbiah","MSKCC_Library","urbano_anido","Miljko","mariavhj23","peterjmeyers","farma_gregorio","nosequedecir22","nmunozm","Monthy_A","pash22","LeedScottish","VincentRK","javierodiaz","fischmd","Oncocluster","ntizimira","a_von","amitabhchandra2","recnac1","ShamMailankody","VinayPrasad82","dgermain21","rbanzi","Tr0ttaFra","TomBurtonWSJ","MrPug94","KariTikkinen","MikkoKeranen","EikBj","oncology_bg","oncoblogger","VR_Cornelius","mdimairo"],"posts_count":37}},"selected_quotes":["We are dealing with an epidemic of crap NI studies and margins; We dealt with oncology here: htt\u2026","+1. Lancet Oncology takes on non-inferiority trials.","Neither Kaplan nor Meier envisioned censoring, ... would be so greatly abused re: non-inferiority trials","Non-inferiority trials: why oncologists must remain wary #revistascient\u00edficas #feedly","We are dealing with an epidemic of crap NI studies and margins; We dealt with oncology here"],"citation":{"altmetric_jid":"4f6fa4f73cf058f610002fd1","authors":["Burotto, Mauricio","Prasad, Vinay","Fojo, Tito","Mauricio Burotto","Vinay Prasad","Tito Fojo"],"doi":"10.1016\/s1470-2045(15)70129-4","first_seen_on":"2015-03-30T15:57:40+00:00","funders":["niehs"],"issns":["1470-2045","14702045","1474-5488"],"issue":"4","journal":"Lancet Oncology","last_mentioned_on":1490225330,"links":["https:\/\/secure.jbs.elsevierhealth.com\/action\/getSharedSiteSession?rc=9&redirect=http%3A%2F%2Fwww.thelancet.com%2Fjournals%2Flanonc%2Farticle%2FPIIS1470-2045%252815%252970129-4%2Fabstract%3Felsca1%3Detoc%26elsca2%3Demail%26elsca3%3D1470-2045_201504_16_4_%26elsca4%3DSurgical%2BOncology%257CInternal%252FFamily%2BMedicine%257CRadiation%2BOncology%257COncology%257CLancet&code=lancet-site","http:\/\/www.sciencedirect.com\/science\/article\/pii\/S1470204515701294","https:\/\/secure.jbs.elsevierhealth.com\/action\/getSharedSiteSession?rc=9&redirect=http%3A%2F%2Fwww.thelancet.com%2Fjournals%2Flanonc%2Farticle%2FPIIS1470-2045%252815%252970129-4%2Ffulltext&code=lancet-site","https:\/\/secure.jbs.elsevierhealth.com\/action\/getSharedSiteSession?rc=9&redirect=http%3A%2F%2Fwww.thelancet.com%2Fjournals%2Flanonc%2Farticle%2FPIIS1470-2045%252815%252970129-4%2Ffulltext%3Frss%3Dyes&code=lancet-site","http:\/\/www.thelancet.com\/journals\/lanonc\/article\/PIIS1470-2045(15)70129-4\/fulltext?rss=yes","https:\/\/secure.jbs.elsevierhealth.com\/action\/getSharedSiteSession?rc=9&redirect=http%3A%2F%2Fwww.thelancet.com%2Fjournals%2Flanonc%2Farticle%2FPIIS1470-2045%252815%252970129-4%2Fabstract&code=lancet-site","https:\/\/secure.jbs.elsevierhealth.com\/action\/getSharedSiteSession?rc=8&redirect=http%3A%2F%2Fwww.thelancet.com%2Fjournals%2Flanonc%2Farticle%2FPIIS1470-2045%252815%252970129-4%2Ffulltext%3Frss%3Dyes&code=lancet-site","http:\/\/www.thelancet.com\/journals\/lanonc\/article\/PIIS1470-2045(15)70129-4\/abstract","http:\/\/thelancet.com\/journals\/lanonc\/article\/PIIS1470-2045%2815%2970129-4\/abstract#.WNFpa7TQs08.twitter"],"pdf_url":"http:\/\/www.thelancet.com\/article\/S1470204515701294\/pdf","pmid":"25846084","pubdate":"2015-04-08T22:04:59+00:00","publisher":"Elsevier","publisher_subjects":[{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"startpage":"364","subjects":["neoplasms"],"title":"Non-inferiority trials: why oncologists must remain wary","type":"article","uri":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1470204515701294","volume":"16","mendeley_url":"http:\/\/www.mendeley.com\/research\/noninferiority-trials-oncologists-remain-wary"},"altmetric_score":{"score":22.95,"score_history":{"1y":7.5,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":22.95},"context_for_score":{"all":{"total_number_of_other_articles":8411114,"mean":7.0796423724108,"rank":391502,"this_scored_higher_than_pct":95,"this_scored_higher_than":8019383,"rank_type":"exact","sample_size":8411114,"percentile":95},"similar_age_3m":{"total_number_of_other_articles":202597,"mean":9.4222937274182,"rank":14238,"this_scored_higher_than_pct":92,"this_scored_higher_than":188344,"rank_type":"exact","sample_size":202597,"percentile":92},"this_journal":{"total_number_of_other_articles":3606,"mean":18.573733148405,"rank":526,"this_scored_higher_than_pct":85,"this_scored_higher_than":3079,"rank_type":"exact","sample_size":3606,"percentile":85},"similar_age_this_journal_3m":{"total_number_of_other_articles":69,"mean":40.409647058824,"rank":12,"this_scored_higher_than_pct":82,"this_scored_higher_than":57,"rank_type":"exact","sample_size":69,"percentile":82}}},"demographics":{"poster_types":{"member_of_the_public":19,"researcher":6,"practitioner":9,"science_communicator":2},"users":{"twitter":{"cohorts":{"Science communicators (journalists, bloggers, editors)":2,"Practitioners (doctors, other healthcare professionals)":9,"Members of the public":19,"Scientists":6}},"mendeley":{"by_status":{"Unspecified":1,"Professor > Associate Professor":4,"Student  > Doctoral Student":2,"Researcher":5,"Student  > Master":1,"Other":2,"Student  > Bachelor":1,"Lecturer > Senior Lecturer":1},"by_discipline":{"Engineering":1,"Medicine and Dentistry":11,"Agricultural and Biological Sciences":2,"Business, Management and Accounting":1,"Unspecified":2}}},"geo":{"twitter":{"US":14,"ES":3,"GB":3,"CL":1,"IN":1,"RW":1,"CA":1,"IT":2,"FI":2,"JP":1},"mendeley":{"JP":1,"GB":2}}},"posts":{"twitter":[{"url":"https:\/\/twitter.com\/ONCOLOGYeditor\/status\/582572037568352256","license":"datasift","citation_ids":[3852049],"posted_on":"2015-03-30T15:56:12+00:00","author":{"name":"Susan Beck","url":"http:\/\/www.cancernetwork.com","image":"https:\/\/pbs.twimg.com\/profile_images\/569984794126086144\/xzyiIB2f_normal.png","description":"Editor of the journal ONCOLOGY. Proud of our 28 years of great review articles & commentary. All opinions my own.","id_on_source":"ONCOLOGYeditor","tweeter_id":"836350267","geo":{"lt":41.1176,"ln":-73.4079,"country":"US"},"followers":148},"tweet_id":"582572037568352256"},{"url":"https:\/\/twitter.com\/RielyMD\/status\/582883580281556992","license":"datasift","citation_ids":[3852049],"posted_on":"2015-03-31T12:34:09+00:00","author":{"name":"Gregory Riely","url":"http:\/\/www.mskcc.org\/cancer-care\/doctor\/gregory-riely","image":"https:\/\/pbs.twimg.com\/profile_images\/417048782061072384\/_0a_yv3o_normal.jpeg","description":"Medical Oncologist at Memorial Sloan Kettering Cancer Center.  Clinical focus on lung and thymic malignancies","id_on_source":"RielyMD","tweeter_id":"301164011","geo":{"lt":43.00035,"ln":-75.4999,"country":"US"},"followers":1717},"tweet_id":"582883580281556992"},{"url":"https:\/\/twitter.com\/RielyMD\/status\/582883757067243521","license":"datasift","rt":["recnac1"],"citation_ids":[3852049],"posted_on":"2015-03-31T12:34:51+00:00","author":{"name":"Gregory Riely","url":"http:\/\/www.mskcc.org\/cancer-care\/doctor\/gregory-riely","image":"https:\/\/pbs.twimg.com\/profile_images\/417048782061072384\/_0a_yv3o_normal.jpeg","description":"Medical Oncologist at Memorial Sloan Kettering Cancer Center.  Clinical focus on lung and thymic malignancies","id_on_source":"RielyMD","tweeter_id":"301164011","geo":{"lt":43.00035,"ln":-75.4999,"country":"US"},"followers":1717},"tweet_id":"582883757067243521"},{"url":"https:\/\/twitter.com\/VivekSubbiah\/status\/582885264042762240","license":"datasift","rt":["recnac1"],"citation_ids":[3852049],"posted_on":"2015-03-31T12:40:51+00:00","author":{"name":"Vivek Subbiah, MD","url":"http:\/\/faculty.mdanderson.org\/Vivek_Subbiah\/","image":"https:\/\/pbs.twimg.com\/profile_images\/576712398289010689\/U2ToqVDv_normal.jpeg","description":"Adult & Peds oncologist! #clinicaltrials #Precisionmedicine,#rarecancers #AYACSM #sarcoma, #cancer #phase1trial Tweets are my own","id_on_source":"VivekSubbiah","tweeter_id":"3085571050","geo":{"lt":29.76328,"ln":-95.36327,"country":"US"},"followers":309},"tweet_id":"582885264042762240"},{"url":"https:\/\/twitter.com\/MSKCC_Library\/status\/582927829702148096","license":"datasift","rt":["RielyMD"],"citation_ids":[3852049],"posted_on":"2015-03-31T15:29:59+00:00","author":{"name":"MSK Library","url":"http:\/\/library.mskcc.org\/blog\/","image":"https:\/\/pbs.twimg.com\/profile_images\/773569331414372353\/EudH_N6e_normal.jpg","description":"Memorial Sloan Kettering Cancer Center Library - Tweets and posts are written by library staff and reflect their personal opinions not necessarily those of MSK.","id_on_source":"MSKCC_Library","tweeter_id":"116484766","geo":{"lt":43.00035,"ln":-75.4999,"country":"US"},"followers":1862},"tweet_id":"582927829702148096"},{"url":"https:\/\/twitter.com\/urbano_anido\/status\/582957883840688128","license":"datasift","citation_ids":[3852049],"posted_on":"2015-03-31T17:29:24+00:00","author":{"name":"Urbano Anido","image":"https:\/\/pbs.twimg.com\/profile_images\/701328985590988800\/dFM9Y8VG_normal.jpg","description":"Father & husband | Scuba-diver | Medical oncologist | Own opinions & thoughts","id_on_source":"urbano_anido","tweeter_id":"2303944103","geo":{"lt":42.88052,"ln":-8.54569,"country":"ES"},"followers":449},"tweet_id":"582957883840688128"},{"url":"https:\/\/twitter.com\/Miljko\/status\/582935188109418496","license":"datasift","citation_ids":[3852049],"posted_on":"2015-03-31T15:59:13+00:00","author":{"name":"Milo\u0161 Miljkovi\u0107","url":"http:\/\/miljko.org","image":"https:\/\/pbs.twimg.com\/profile_images\/761157004052221953\/Zrztc1P__normal.jpg","description":"\ud83c\uddfa\ud83c\uddf8\u00a0An oncologist in Bethesda, federal employee;\ud83d\udd2cATL, IL-15, and do ask me about Tbata; \ud83c\uddf7\ud83c\uddf8 Internista, onkolog, strani pla\u0107enik","id_on_source":"Miljko","tweeter_id":"14756717","geo":{"lt":38.91706,"ln":-77.00025,"country":"US"},"followers":472},"tweet_id":"582935188109418496"},{"url":"https:\/\/twitter.com\/mariavhj23\/status\/587677297727168513","license":"datasift","citation_ids":[3852049],"posted_on":"2015-04-13T18:02:40+00:00","author":{"name":"Mar\u00eda Vuelta","image":"https:\/\/pbs.twimg.com\/profile_images\/809824622719930368\/6jR1I6fO_normal.jpg","description":"Farmacia Hospitalaria","id_on_source":"mariavhj23","tweeter_id":"1280201330","geo":{"lt":null,"ln":null},"followers":130},"tweet_id":"587677297727168513"},{"url":"https:\/\/twitter.com\/peterjmeyers\/status\/587960606738649088","license":"datasift","rt":["amitabhchandra2"],"citation_ids":[3852049],"posted_on":"2015-04-14T12:48:27+00:00","author":{"name":"Peter Meyers","url":"https:\/\/www.facebook.com\/UnitedFamilyMedicine","image":"https:\/\/pbs.twimg.com\/profile_images\/890571670301364224\/RdqB91Mi_normal.jpg","description":"MD, MPH. PGY-3 at @unitedfamilymed. Collaborating with @mnfamilydocs, @pcareprogress, and @md4healthequity too.","id_on_source":"peterjmeyers","tweeter_id":"17565279","geo":{"lt":44.94441,"ln":-93.09327,"country":"US"},"followers":255},"tweet_id":"587960606738649088"},{"url":"https:\/\/twitter.com\/farma_gregorio\/status\/588779181447741440","license":"datasift","citation_ids":[3852049],"posted_on":"2015-04-16T19:01:10+00:00","author":{"name":"S. Farmacia Gregorio","url":"http:\/\/www.madrid.org\/hospitalgregoriomaranon\/farmacia","image":"https:\/\/pbs.twimg.com\/profile_images\/491603015074582528\/AUhNp4o8_normal.jpeg","id_on_source":"farma_gregorio","tweeter_id":"2669297948","geo":{"lt":null,"ln":null},"followers":1542},"tweet_id":"588779181447741440"},{"url":"https:\/\/twitter.com\/nosequedecir22\/status\/588782002037530624","license":"datasift","rt":["farma_gregorio"],"citation_ids":[3852049],"posted_on":"2015-04-16T19:12:22+00:00","author":{"name":"Sandra Flores","image":"https:\/\/pbs.twimg.com\/profile_images\/878710169953341441\/DIDrmSJ2_normal.jpg","description":"Farmaceutica de hospital  con muchas ganas de vivir,feliz y con mucho sue\u00f1o!","id_on_source":"nosequedecir22","tweeter_id":"2182278911","geo":{"lt":null,"ln":null},"followers":358},"tweet_id":"588782002037530624"},{"url":"https:\/\/twitter.com\/nmunozm\/status\/588943382652837888","license":"datasift","rt":["farma_gregorio"],"citation_ids":[3852049],"posted_on":"2015-04-17T05:53:39+00:00","author":{"name":"Nuria M","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000029364499\/ac8ec655bb21468f98676518a306abd6_normal.jpeg","description":"Farmacia Hospitalaria y Comunitaria. Oncologica. BCOP. Aficionada al WP","id_on_source":"nmunozm","tweeter_id":"1538759965","geo":{"lt":37.38241,"ln":-5.97613,"country":"ES"},"followers":589},"tweet_id":"588943382652837888"},{"url":"https:\/\/twitter.com\/Monthy_A\/status\/588944665870786560","license":"datasift","rt":["farma_gregorio"],"citation_ids":[3852049],"posted_on":"2015-04-17T05:58:45+00:00","author":{"name":"Angel Montero Luis","url":"http:\/\/about.me\/angel.montero.luis","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000059163044\/19c930b305d0a68452bdd2c0ddde72d8_normal.png","description":"La duda mueve el mundo \u00bfT\u00fa dudas?","id_on_source":"Monthy_A","tweeter_id":"357411717","geo":{"lt":40.42526,"ln":-3.69063,"country":"ES"},"followers":1275},"tweet_id":"588944665870786560"},{"url":"https:\/\/twitter.com\/pash22\/status\/591303586723815424","license":"datasift","citation_ids":[3852049],"posted_on":"2015-04-23T18:12:15+00:00","author":{"name":"Ash Paul","image":"https:\/\/pbs.twimg.com\/profile_images\/3295856896\/66ab958422d28c521d0143bddbb90233_normal.jpeg","description":"Public Hlth Dr,interested in evid-based health services commissioning,clinical leadership & hlth policy.My views are my own,RTs are no endorsements","id_on_source":"pash22","tweeter_id":"28824136","geo":{"lt":54.75844,"ln":-2.69531,"country":"GB"},"followers":20609},"tweet_id":"591303586723815424"},{"url":"https:\/\/twitter.com\/LeedScottish\/status\/591307922468114432","license":"datasift","rt":["pash22"],"citation_ids":[3852049],"posted_on":"2015-04-23T18:29:29+00:00","author":{"name":"David Thomson","image":"https:\/\/pbs.twimg.com\/profile_images\/2790503139\/62f42e2d2b469d5fcaf2701e99c1c9b9_normal.png","description":"Oncology pharmacist. Interested in drug access, the NHS and the pharmacy profession. MSc in International HTA, Pricing and Reimbursement.","id_on_source":"LeedScottish","tweeter_id":"150237339","geo":{"lt":53.79648,"ln":-1.54785,"country":"GB"},"followers":248},"tweet_id":"591307922468114432"},{"url":"https:\/\/twitter.com\/VincentRK\/status\/592019538260140032","license":"datasift","rt":["recnac1"],"citation_ids":[3852049],"posted_on":"2015-04-25T17:37:11+00:00","author":{"name":"Vincent Rajkumar","url":"http:\/\/bit.ly\/Z4PHPv","image":"https:\/\/pbs.twimg.com\/profile_images\/3418263560\/a40cbe1b5676b01dff5a8eb86e87c099_normal.jpeg","description":"Edward W & Betty Knight Scripps Professor, Mayo Clinic; Editor, Blood Cancer J; Assoc Editor, Mayo Clin Proceedings; No Financial COI http:\/\/tinyurl.com\/houbsqb","id_on_source":"VincentRK","tweeter_id":"24261916","geo":{"lt":44.02163,"ln":-92.4699,"country":"US"},"followers":5390},"tweet_id":"592019538260140032"},{"url":"https:\/\/twitter.com\/javierodiaz\/status\/592326878582693888","license":"datasift","rt":["recnac1"],"citation_ids":[3852049],"posted_on":"2015-04-26T13:58:27+00:00","author":{"name":"Javier Diaz Vidal","image":"https:\/\/pbs.twimg.com\/profile_images\/2992801185\/5933e959157d10ee60774de9e06d14f2_normal.jpeg","description":"Resilient hematologist at Dr. Gustavo Fricke Hospital, Vi\u00f1a del Mar, Chile","id_on_source":"javierodiaz","tweeter_id":"101652976","geo":{"lt":-33.02457,"ln":-71.55183,"country":"CL"},"followers":305},"tweet_id":"592326878582693888"},{"url":"https:\/\/twitter.com\/fischmd\/status\/592462100620046336","license":"datasift","rt":["recnac1"],"citation_ids":[3852049],"posted_on":"2015-04-26T22:55:46+00:00","author":{"name":"Michael Fisch","url":"http:\/\/www.aimspecialtyhealth.com","image":"https:\/\/pbs.twimg.com\/profile_images\/600386570080780288\/ago1KktK_normal.jpg","description":"Med Onc, Internal Med, Palliative Care. AIM Specialty Health, MD Anderson Cancer Ctr. UVa grad (CLAS, MED). Tweets are mine: #hpm #meded #pallonc, #hpeonc","id_on_source":"fischmd","tweeter_id":"257010511","geo":{"lt":41.85003,"ln":-87.65005,"country":"US"},"followers":18384},"tweet_id":"592462100620046336"},{"url":"https:\/\/twitter.com\/Oncocluster\/status\/592539022402199552","license":"datasift","citation_ids":[3852049],"posted_on":"2015-04-27T04:01:26+00:00","author":{"name":"Oncocluster","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000081475855\/bfdc6d590bf4fc94f800f2a2e4c2c161_normal.jpeg","description":"An XRays Biocom initiative to encourage discussion, dialogue and debate in the sphere of Oncology","id_on_source":"Oncocluster","tweeter_id":"1565298146","geo":{"lt":19.07283,"ln":72.88261,"country":"IN"},"followers":169},"tweet_id":"592539022402199552"},{"url":"https:\/\/twitter.com\/ntizimira\/status\/592552794508435456","license":"datasift","rt":["recnac1"],"citation_ids":[3852049],"posted_on":"2015-04-27T04:56:09+00:00","author":{"name":"Christian Ntizimira","image":"https:\/\/pbs.twimg.com\/profile_images\/459007617893797889\/Z7QIC3vp_normal.jpeg","description":"Palliative Care Expert & Educator; Pain Policy Advocate; RPCHO&AORTIC Member, Tweets= my own opinion","id_on_source":"ntizimira","tweeter_id":"366024467","geo":{"lt":-2,"ln":30,"country":"RW"},"followers":1467},"tweet_id":"592552794508435456"},{"url":"https:\/\/twitter.com\/a_von\/status\/600974845740875777","license":"datasift","rt":["amitabhchandra2"],"citation_ids":[3852049],"posted_on":"2015-05-20T10:42:23+00:00","author":{"name":"Ahmad von Schlegell","image":"https:\/\/pbs.twimg.com\/profile_images\/541654896173662209\/3PraQuZB_normal.jpeg","description":"geriatrician, palliative care physician, epidemiologist, and budding phd health economist.","id_on_source":"a_von","tweeter_id":"46135294","geo":{"lt":43.70011,"ln":-79.4163,"country":"CA"},"followers":125},"tweet_id":"600974845740875777"},{"url":"https:\/\/twitter.com\/amitabhchandra2\/status\/587956586947223552","license":"datasift","citation_ids":[3852049],"posted_on":"2015-04-14T12:32:28+00:00","author":{"name":"Amitabh Chandra","url":"https:\/\/www.hks.harvard.edu\/about\/faculty-staff-directory\/amitabh-chandra\/","image":"https:\/\/pbs.twimg.com\/profile_images\/3106205978\/c0f17b63b38e9912ed86a39c656bad12_normal.jpeg","description":"Economist who blocks trolls. Tweets about piano, affogatos, foie gras, german cars, Game of Thrones, India, hippies...occasionally, healthcare","id_on_source":"amitabhchandra2","tweeter_id":"1087859256","geo":{"lt":42.50009,"ln":-71.58284,"country":"US"},"followers":9781},"tweet_id":"587956586947223552"},{"url":"https:\/\/twitter.com\/recnac1\/status\/582881559226621953","license":"datasift","citation_ids":[3852049],"posted_on":"2015-03-31T12:26:07+00:00","author":{"name":"Lee Ellis","url":"http:\/\/faculty.mdanderson.org\/Lee_Ellis\/Default.asp?SNID=0","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000059398712\/de7ac036c71d31c45a708fb6530ee833_normal.jpeg","description":"Physician\/scientist at MD Anderson Cancer Ctr. Vice-Chair- SWOG Translational Medicine. Past Chair ASCO Can Res Comm. Deputy Editor JAMA Onc, Tweets are my own.","id_on_source":"recnac1","tweeter_id":"237468540","geo":{"lt":null,"ln":null},"followers":1114},"tweet_id":"582881559226621953"},{"url":"http:\/\/twitter.com\/ShamMailankody\/statuses\/701193551011586048","license":"gnip","citation_ids":[3852049],"posted_on":"2016-02-20T23:55:44+00:00","author":{"name":"Sham Mailankody","image":"https:\/\/pbs.twimg.com\/profile_images\/652457241052848129\/G3gv1Mvg_normal.jpg","description":"Medical oncologist @sloan_kettering specializing in multiple myeloma. My interests include clinical research and cancer health policy. Views\/tweets are mine","id_on_source":"ShamMailankody","tweeter_id":"2312680111","geo":{"lt":43.00035,"ln":-75.4999,"country":"US"},"followers":634},"tweet_id":"701193551011586048"},{"url":"http:\/\/twitter.com\/VinayPrasad82\/statuses\/844226396280901632","license":"gnip","citation_ids":[3852049],"posted_on":"2017-03-21T16:37:12+00:00","author":{"name":"Vinay Prasad","url":"http:\/\/vinayakkprasad.com","image":"https:\/\/pbs.twimg.com\/profile_images\/874283904584138754\/SKCzllHj_normal.jpg","description":"#researchparasite interested in policy, heme-onc, EBM & medical reversal; Specialize in lymphoma; Author of: https:\/\/t.co\/8mRKay1ufn\nFunded by @LJA_Foundation","id_on_source":"VinayPrasad82","tweeter_id":"1194962714","geo":{"lt":45.52345,"ln":-122.67621,"country":"US"},"followers":12153},"tweet_id":"844226396280901632"},{"url":"http:\/\/twitter.com\/dgermain21\/statuses\/844229394860298240","license":"gnip","rt":["VinayPrasad82"],"citation_ids":[3852049],"posted_on":"2017-03-21T16:49:07+00:00","author":{"name":"D. Russler-Germain","image":"https:\/\/pbs.twimg.com\/profile_images\/724019223127678978\/K5RNn4Of_normal.jpg","description":"MD-PhD. Hematology\/oncology physician-scientist-in-training. Tweet\/RT not medical advice or endorsement.","id_on_source":"dgermain21","tweeter_id":"18821994","geo":{"lt":38.62727,"ln":-90.19789,"country":"US"},"followers":976},"tweet_id":"844229394860298240"},{"url":"http:\/\/twitter.com\/rbanzi\/statuses\/844235026279600129","license":"gnip","rt":["VinayPrasad82"],"citation_ids":[3852049],"posted_on":"2017-03-21T17:11:30+00:00","author":{"name":"Rita Banzi","image":"https:\/\/pbs.twimg.com\/profile_images\/686660051562528769\/reDHnslP_normal.jpg","description":"Let's invest something in research, if we are lucky we'll find something...","id_on_source":"rbanzi","tweeter_id":"38425916","geo":{"lt":null,"ln":null},"followers":46},"tweet_id":"844235026279600129"},{"url":"http:\/\/twitter.com\/Tr0ttaFra\/statuses\/844246501903794177","license":"gnip","citation_ids":[3852049],"posted_on":"2017-03-21T17:57:06+00:00","author":{"name":"Francesco Trotta","image":"https:\/\/pbs.twimg.com\/profile_images\/837710433427537921\/PIdSZLh8_normal.jpg","description":"Pharmacoepi researcher, expert in drug regulation. Opinions are my own. RTs do not imply endorsement.","id_on_source":"Tr0ttaFra","tweeter_id":"720582432223817728","geo":{"lt":41.90036,"ln":12.49575,"country":"IT"},"followers":194},"tweet_id":"844246501903794177"},{"url":"http:\/\/twitter.com\/TomBurtonWSJ\/statuses\/844248725497233408","license":"gnip","rt":["VinayPrasad82"],"citation_ids":[3852049],"posted_on":"2017-03-21T18:05:56+00:00","author":{"name":"Tom Burton","image":"https:\/\/pbs.twimg.com\/profile_images\/3429921186\/485d2266c3e476ba243d3c9034ea7d0f_normal.jpeg","description":"Staff reporter at Wall Street Journal @WSJ on medicine, FDA, NIH. Pulitzer Prize winner. Husband, dad; ND fan. @Dartmouth @GeorgetownLaw Tom.Burton@wsj.com","id_on_source":"TomBurtonWSJ","tweeter_id":"588554500","geo":{"lt":38.91706,"ln":-77.00025,"country":"US"},"followers":4995},"tweet_id":"844248725497233408"},{"url":"http:\/\/twitter.com\/MrPug94\/statuses\/844285171444563968","license":"gnip","rt":["VinayPrasad82"],"citation_ids":[3852049],"posted_on":"2017-03-21T20:30:45+00:00","author":{"name":"Brian Shields","url":"http:\/\/www.latimes.com\/business\/la-fi-genentech-tarceva-settlement-20160607-snap-story.html","image":"https:\/\/pbs.twimg.com\/profile_images\/753058072768098304\/6Fqger_P_normal.jpg","description":"Former Army Aviator, USMA grad, Cancer Advocate, Pharma Whistleblower","id_on_source":"MrPug94","tweeter_id":"164254921","geo":{"lt":37.25022,"ln":-119.75126,"country":"US"},"followers":6117},"tweet_id":"844285171444563968"},{"url":"http:\/\/twitter.com\/KariTikkinen\/statuses\/844322746825871360","license":"gnip","rt":["VinayPrasad82"],"citation_ids":[3852049],"posted_on":"2017-03-21T23:00:04+00:00","author":{"name":"Kari Tikkinen","url":"http:\/\/clueworkinggroup.com","image":"https:\/\/pbs.twimg.com\/profile_images\/663381934438002688\/a4z9vRgi_normal.jpg","description":"Urologist\/clinical epidemiologist at UofHelsinki. Chair\/member of EAU Thromboprophylaxis\/LUTS Guidelines. PI of the CLUE Working Group https:\/\/t.co\/V36IjSyWhl","id_on_source":"KariTikkinen","tweeter_id":"2841368445","geo":{"lt":60.16952,"ln":24.93545,"country":"FI"},"followers":1049},"tweet_id":"844322746825871360"},{"url":"http:\/\/twitter.com\/MikkoKeranen\/statuses\/844418393272922112","license":"gnip","rt":["VinayPrasad82"],"citation_ids":[3852049],"posted_on":"2017-03-22T05:20:08+00:00","author":{"name":"Mikko Ker\u00e4nen","url":"http:\/\/www.helsinki.fi\/hematology\/eng_index.html","image":"https:\/\/pbs.twimg.com\/profile_images\/687735956338782208\/1i-FlI62_normal.jpg","description":"MD, PhD, clinician and postdoctoral fellow in @hruh_research, University of Helsinki, Finland. #helsinkichallenge","id_on_source":"MikkoKeranen","tweeter_id":"143497547","geo":{"lt":60.16952,"ln":24.93545,"country":"FI"},"followers":446},"tweet_id":"844418393272922112"},{"url":"http:\/\/twitter.com\/EikBj\/statuses\/844440676678938624","license":"gnip","rt":["VinayPrasad82"],"citation_ids":[3852049],"posted_on":"2017-03-22T06:48:40+00:00","author":{"name":"Eik Bjerre","image":"https:\/\/pbs.twimg.com\/profile_images\/581848101788450817\/IdBG_MU9_normal.jpg","description":"PhD student working on systematic reviews and the FC Prostate Community Trial. Follow the scientific development here. Views my own.","id_on_source":"EikBj","tweeter_id":"3124159966","geo":{"lt":null,"ln":null},"followers":206},"tweet_id":"844440676678938624"},{"url":"http:\/\/twitter.com\/oncology_bg\/statuses\/844498926900195329","license":"gnip","rt":["VinayPrasad82"],"citation_ids":[3852049],"posted_on":"2017-03-22T10:40:08+00:00","author":{"name":"Bishal Gyawali","url":"http:\/\/www.researchgate.net\/profile\/Bishal_Gyawali2","image":"https:\/\/pbs.twimg.com\/profile_images\/880239949173317633\/ivis7jAc_normal.jpg","description":"#MedicalOncology #GlobalOncology #cancerpolicy #cancercare in #LMICs #supportivecare #financialtoxicity  Blogs @ecancer .http:\/\/bit.ly\/2a6H3oy No #FCOI","id_on_source":"oncology_bg","tweeter_id":"3511138520","geo":{"lt":35.18147,"ln":136.90641,"country":"JP"},"followers":2306},"tweet_id":"844498926900195329"},{"url":"http:\/\/twitter.com\/oncoblogger\/statuses\/844583330167361536","license":"gnip","rt":["VinayPrasad82"],"citation_ids":[3852049],"posted_on":"2017-03-22T16:15:32+00:00","author":{"name":"Oncoblogger","url":"https:\/\/paper.li\/oncoblogger\/1394190713","image":"https:\/\/pbs.twimg.com\/profile_images\/2124848055\/image_normal.jpg","description":"Medical Oncologist. Independent, not sponsored tweeting about clinical research in medical oncology, supportive care and cancer health policy.","id_on_source":"oncoblogger","tweeter_id":"33449751","geo":{"lt":41.89474,"ln":12.4839,"country":"IT"},"followers":601},"tweet_id":"844583330167361536"},{"url":"http:\/\/twitter.com\/VR_Cornelius\/statuses\/844689901027241989","license":"gnip","rt":["Tr0ttaFra"],"citation_ids":[3852049],"posted_on":"2017-03-22T23:19:00+00:00","author":{"name":"Victoria Cornelius","image":"https:\/\/pbs.twimg.com\/profile_images\/883685226148450304\/FPZKnn2J_normal.jpg","description":"Statistician interested in clinical trials and methods to evaluate drug safety","id_on_source":"VR_Cornelius","tweeter_id":"3380267218","geo":{"lt":51.50853,"ln":-0.12574,"country":"GB"},"followers":163},"tweet_id":"844689901027241989"},{"url":"http:\/\/twitter.com\/mdimairo\/statuses\/844692374186053633","license":"gnip","rt":["Tr0ttaFra"],"citation_ids":[3852049],"posted_on":"2017-03-22T23:28:50+00:00","author":{"name":"Munya Dimairo","url":"https:\/\/goo.gl\/rErXpc","image":"https:\/\/pbs.twimg.com\/profile_images\/910032050715021312\/eo-lZpyB_normal.jpg","description":"Science addict, Research Fellow, Trials Methodology, always thinks in an abstract way, amateur footy player & a GUNNER. Views are my own. RT \u2260 ENDORSEMENT","id_on_source":"mdimairo","tweeter_id":"168748818","geo":{"lt":null,"ln":null},"followers":671},"tweet_id":"844692374186053633"}],"facebook":[{"title":"Non-inferiority trials: why oncologists must remain wary","url":"https:\/\/www.facebook.com\/291286767653940\/posts\/772431719539440","license":"public","citation_ids":[3852049],"posted_on":"2015-04-01T01:02:46+00:00","summary":"Heightened interest in comparative effectiveness research has made head-to-head comparisons between anti-cancer drugs increasingly common. One strategy is to show non-inferiority of a therapy to another in terms of efficacy and to rely on \u2026","author":{"name":"Journal Club for Basic Bio-Medical Sciences & Clinical Medicine","url":"https:\/\/www.facebook.com\/291286767653940","facebook_wall_name":"Journal Club for Basic Bio-Medical Sciences & Clinical Medicine","image":"https:\/\/graph.facebook.com\/291286767653940\/picture","id_on_source":"291286767653940"}}]}}